GSK (GSK) News Today $37.76 +0.18 (+0.48%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$37.95 +0.19 (+0.51%) As of 08/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GSK Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK3 hours ago | globenewswire.comGoldman Sachs Group Inc. Reduces Stock Position in GSK PLC Sponsored ADR (NYSE:GSK)August 9 at 5:04 AM | marketbeat.comGSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to KnowAugust 8 at 12:38 PM | tipranks.comGSK’s New Study on Multiple Myeloma Treatment: What Investors Need to KnowAugust 8 at 12:38 PM | tipranks.comGSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?August 8 at 12:38 PM | tipranks.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Sold by Arjuna CapitalAugust 8 at 7:03 AM | marketbeat.comGSK to Receive $370 Million in U.S. Patent Litigation SettlementAugust 8 at 3:31 AM | wsj.comPrimecap Management Co. CA Increases Holdings in GSK PLC Sponsored ADR (NYSE:GSK)August 7 at 7:33 AM | marketbeat.comGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung DiseaseAugust 6 at 12:36 PM | tipranks.comGSK’s RSV Vaccine Study: A Potential Game-Changer for Older AdultsAugust 5, 2025 | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSKAugust 5, 2025 | globenewswire.comGSK PLC Sponsored ADR (NYSE:GSK) Shares Purchased by Natixis Advisors LLCAugust 5, 2025 | marketbeat.comFederated Hermes Inc. Grows Stock Holdings in GSK PLC Sponsored ADR (NYSE:GSK)August 5, 2025 | marketbeat.comLPL Financial LLC Grows Stock Holdings in GSK PLC Sponsored ADR (NYSE:GSK)August 5, 2025 | marketbeat.comUS Bancorp DE Acquires 9,473 Shares of GSK PLC Sponsored ADR (NYSE:GSK)August 5, 2025 | marketbeat.comGSK (NYSE:GSK) Stock Rating Upgraded by Wall Street ZenAugust 5, 2025 | americanbankingnews.comMackenzie Financial Corp Takes $5.97 Million Position in GSK PLC Sponsored ADR (NYSE:GSK)August 3, 2025 | marketbeat.comGSK (NYSE:GSK) Upgraded by Wall Street Zen to Buy RatingAugust 3, 2025 | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Stock Holdings Lowered by Mesirow Financial Investment Management Inc.August 2, 2025 | marketbeat.comArkadios Wealth Advisors Raises Stock Holdings in GSK PLC Sponsored ADR (NYSE:GSK)August 2, 2025 | marketbeat.comGSK PLC Sponsored ADR (NYSE:GSK) Declares $0.42 Quarterly DividendAugust 1, 2025 | marketbeat.comGSK’s New Phase 3 Study: A Potential Game-Changer in Lung Cancer TreatmentAugust 1, 2025 | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSKAugust 1, 2025 | globenewswire.comCetera Investment Advisers Grows Stock Position in GSK PLC Sponsored ADR (NYSE:GSK)August 1, 2025 | marketbeat.comAnalysts Have Made A Financial Statement On GSK plc's (LON:GSK) Interim ReportAugust 1, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSKJuly 31, 2025 | prnewswire.comGSK (NYSE:GSK) Updates FY 2025 Earnings GuidanceJuly 31, 2025 | marketbeat.comGSK plc (GSK) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comGSK in talks with Trump administration on U.S. drug pricing, CEO saysJuly 30, 2025 | reuters.comGSK expects annual sales and profit at top end of forecast rangeJuly 30, 2025 | reuters.comGSK’s Belimumab Study: A Potential Game-Changer for Early SLE TreatmentJuly 29, 2025 | tipranks.comGSK Sales, Core Earnings Expected to Edge Lower -- Earnings PreviewJuly 29, 2025 | marketwatch.comAssetmark Inc. Purchases 26,754 Shares of GSK PLC Sponsored ADR (NYSE:GSK)July 29, 2025 | marketbeat.comChina Market Update: Health Care Surges On Hengrui-GSK Deal, Market Cheers US-EU Trade AgreementJuly 28, 2025 | forbes.comGSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA ApprovalJuly 28, 2025 | seekingalpha.comGSK’s Long-Term Study on Atopic Dermatitis Drug: A Potential Game Changer?July 28, 2025 | tipranks.comGSK’s Innovative Hepatitis B Treatment Study: A Potential Game-Changer?July 28, 2025 | tipranks.comGSK’s Promising Phase 3 Study on Belimumab for ILD: Key Insights for InvestorsJuly 28, 2025 | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSKJuly 28, 2025 | globenewswire.comJiangsu Hengrui Pharma stock spikes 10% to 4-year high on drug development deal with GSK – here’s what the company doesJuly 28, 2025 | msn.comGSK, China's Jiangsu Hengrui strike $500 million drug-development dealJuly 28, 2025 | msn.comAvantax Advisory Services Inc. Grows Holdings in GSK PLC Sponsored ADR (NYSE:GSK)July 28, 2025 | marketbeat.comJiangsu Hengrui grants GSK global rights to drug portfolio in $500 million dealJuly 27, 2025 | reuters.comHengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and OncologyJuly 27, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc - GSKJuly 27, 2025 | prnewswire.comKranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Has $2.70 Million Holdings in GSK PLC Sponsored ADR (NYSE:GSK)July 27, 2025 | marketbeat.comKranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD Lowers Stake in GSK PLC Sponsored ADR (NYSE:GSK)July 27, 2025 | marketbeat.com9,064 Shares in GSK PLC Sponsored ADR (NYSE:GSK) Acquired by First Heartland Consultants Inc.July 27, 2025 | marketbeat.comPrivate Advisor Group LLC Sells 7,121 Shares of GSK PLC Sponsored ADR (NYSE:GSK)July 26, 2025 | marketbeat.comGSK (NYSE:GSK) Rating Lowered to Hold at Wall Street ZenJuly 26, 2025 | marketbeat.com Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address GSK Media Mentions By Week GSK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GSK News Sentiment▼0.910.45▲Average Medical News Sentiment GSK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GSK Articles This Week▼1720▲GSK Articles Average Week Get GSK News Delivered to You Automatically Sign up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novartis News Today AstraZeneca News Today Novo Nordisk A/S News Today Sanofi News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Summit Therapeutics News Today Insmed News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GSK) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GSK PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share GSK With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GSK Stock Alerts